Leuprolide Acetate Patents

Given below is the list of patents protecting Leuprolide Acetate, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Leuprolide Acetate's patents.

Latest Legal Activities on Leuprolide Acetate's Patents

Given below is the list recent legal activities going on the following patents of Leuprolide Acetate.

Activity	Date	Patent Number
Critical Events for all Patents
Correspondence Address Change Critical	23 Jun, 2016	US6395292
Change in Power of Attorney (May Include Associate POA) Critical	24 Mar, 2015	US6395292
Correspondence Address Change Critical	23 Mar, 2015	US6395292
Correspondence Address Change Critical	26 Feb, 2008	US6395292
Change in Power of Attorney (May Include Associate POA) Critical	31 Jan, 2008	US6395292
Correspondence Address Change Critical	31 Jan, 2008	US6395292
Patent Issue Date Used in PTA Calculation Critical	28 May, 2002	US6395292
Recordation of Patent Grant Mailed Critical	28 May, 2002	US6395292
Issue Notification Mailed Critical	10 May, 2002	US6395292
Receipt into Pubs	02 May, 2002	US6395292

Leuprolide Acetate's Family Patents

Full family tree